Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103695933 | 10369593 | 3 | F | 20160222 | 20140807 | 20160922 | PER | US-AMGEN INC.-USASP2014024251 | AMGEN | 55.00 | YR | A | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103695933 | 10369593 | 1 | PS | filgrastim | FILGRASTIM | 1 | Subcutaneous | 480 MUG, UNK | U | 103353 | 480 | UG | UNKNOWN FORMULATION | ||||||
103695933 | 10369593 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 0 | 2 | MG/KG | ||||||||
103695933 | 10369593 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 350 MG, UNK | 0 | 350 | MG | ||||||||
103695933 | 10369593 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 110 MG, UNK | 0 | 110 | MG | ||||||||
103695933 | 10369593 | 5 | C | PROCRIT | ERYTHROPOIETIN | 1 | 40000 UNITS, UNK | 0 | UNKNOWN FORMULATION | ||||||||||
103695933 | 10369593 | 6 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 4 MG, UNK | 0 | 4 | MG | ||||||||
103695933 | 10369593 | 7 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 10 MG, UNK | 0 | 10 | MG | ||||||||
103695933 | 10369593 | 8 | C | TAXOL | PACLITAXEL | 1 | 110 MG, UNK | 0 | 110 | MG | |||||||||
103695933 | 10369593 | 9 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0.25 MG, UNK | 0 | .25 | MG | ||||||||
103695933 | 10369593 | 10 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 25 MG, UNK | 0 | 25 | MG | ||||||||
103695933 | 10369593 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
103695933 | 10369593 | 12 | C | PEPCID | FAMOTIDINE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
103695933 | 10369593 | 13 | C | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | 93 MG, UNK | 0 | 93 | MG | |||||||||
103695933 | 10369593 | 14 | C | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 930 MG, UNK | 0 | 930 | MG | |||||||||
103695933 | 10369593 | 15 | C | EMEND | APREPITANT | 1 | 125 MG, UNK | 0 | 125 | MG | |||||||||
103695933 | 10369593 | 16 | C | ARIMIDEX | ANASTROZOLE | 1 | 1 MG, UNK | 0 | 1 | MG | TABLET | ||||||||
103695933 | 10369593 | 17 | C | ONDANSETRON | ONDANSETRON | 1 | 8 MG, UNK | 0 | 8 | MG | TABLET | ||||||||
103695933 | 10369593 | 18 | C | PREVACID | LANSOPRAZOLE | 1 | 30 MG, UNK | 0 | 30 | MG | CAPSULE | ||||||||
103695933 | 10369593 | 19 | C | MEGACE | MEGESTROL ACETATE | 1 | Oral | 400 MG, UNK | 0 | 400 | MG | ||||||||
103695933 | 10369593 | 20 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 25 MG, UNK | 0 | 25 | MG | TABLET | ||||||||
103695933 | 10369593 | 21 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 50,000 UNITS, UNK | 0 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
103695933 | 10369593 | 1 | Product used for unknown indication |
103695933 | 10369593 | 2 | Breast cancer |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
103695933 | 10369593 | Decreased appetite | |
103695933 | 10369593 | Depression | |
103695933 | 10369593 | Fatigue | |
103695933 | 10369593 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
103695933 | 10369593 | 3 | 20111004 | 0 |